122 related articles for article (PubMed ID: 33906292)
41. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
[TBL] [Abstract][Full Text] [Related]
42. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
43. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
[TBL] [Abstract][Full Text] [Related]
44. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.
Yuanming L; Lineng Z; Baorong S; Junjie P; Sanjun C
BMC Cancer; 2013 Mar; 13():103. PubMed ID: 23496813
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathological significance and prognostic implication of nuclear factor-κB activation in colorectal cancer.
Pyo JS; Kim EK
Pathol Res Pract; 2019 Aug; 215(8):152469. PubMed ID: 31201065
[TBL] [Abstract][Full Text] [Related]
46. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
48. Activating transcription factor 1 is a prognostic marker of colorectal cancer.
Huang GL; Guo HQ; Yang F; Liu OF; Li BB; Liu XY; Lu Y; He ZW
Asian Pac J Cancer Prev; 2012; 13(3):1053-7. PubMed ID: 22631637
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
50. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
[TBL] [Abstract][Full Text] [Related]
51. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
52. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer. Experience from Al-Madinah Al-Munawarah, Saudi Arabia.
Albasri AM; Elkablawy MA
Saudi Med J; 2019 Sep; 40(9):893-900. PubMed ID: 31522216
[TBL] [Abstract][Full Text] [Related]
54. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
[TBL] [Abstract][Full Text] [Related]
55. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
Zheng L; Xie G; Duan G; Yan X; Li Q
PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
[TBL] [Abstract][Full Text] [Related]
56. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract][Full Text] [Related]
57. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
[TBL] [Abstract][Full Text] [Related]
59. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
60. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
